FGF1 and cardiomyopathy: Previous studies had reported that FGF1 suppressed the oxidative stress and consequently blocked diabetes‐induced cardiomyopathy.16 Our current study has found that FGF1 treatment blocked the diabetes‐induced oxidative stress during DN.